The genetic basis of primary disorders of intestinal fat transport

Clinical and Investigative Medicine

Volumn 19, Issue 5, 1996, Pages 317-324

  Levy, Émile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ABETALIPOPROTEINEMIA; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DISEASE ASSOCIATION; FAILURE TO THRIVE; GENETIC DISORDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOBETALIPOPROTEINEMIA; INTESTINE ABSORPTION; LIPID ABSORPTION; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN DEFICIENCY; LIPOPROTEIN METABOLISM; MALABSORPTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL IMPAIRMENT; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

ANIMALS; APOLIPOPROTEINS; BIOLOGICAL TRANSPORT; HUMANS; INTESTINAL DISEASES; LIPOPROTEINS;

EID: 0029808886     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (75)

1. Black DD. Intestinal lipoprotein metabolism. J Pediatr Gastroenterol Nutr 1995;20:125-47.
2. Hamilton RL. Apolipoprotein-B-containing plasma lipoproteins in health and in disease. Trends Cardiovasc Med 1994;4:131-9.
3. Levy E. The 1991 Borden Award Lecture: Selected aspects of intraluminal and intracellular phases of intestinal fat absorption. Can J Physiol Pharmacol 1992;70:413-9.
4. Havel RJ. Lipid transport function of lipoproteins in blood plasma [review]. Am J Physiol 1987;253; (1P1):E1-5.
5. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apo-lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill, 1995:1853-85.
6. Breslow JL. Apolipoprotein genetic variation and human disease. Physiol Rev 1988;68:85-132.
7. Levy E, Chouraqui JP, Roy CC. Steatorrhea and disorders of chylomicron synthesis and secretion. Pediatr Clin North Am 1988;35:43-66.
8. Levy E, Lepage G, Bendayan M, Ronco N, Thibault L, Galeano N, et al. Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients. J Lipid Res 1989;30:1197-209.
9. Young SG. Recent progress in understanding apolipoprotein B. Circulation 1990;82:1574-94.
10. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia (increased protein but normal cholesterol levels in human plasma low density β lipoproteins). Proc Natl Acad Sci U S A 1980;77:605-8.
11. Tso P. Intestinal lipid absorption. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven Press, 1994:1867-907.
12. Windmueller HG, Levy RI. Production of β-lipoproteins by the intestine in the rat. J Biol Chem 1968;243:4878-84.
13. Green PHR, Tall AR, Glickman RM. Rat intestine secretes discoid high density lipoprotein. J Clin Invest 1978;61:528-34.
14. Magun AM, Brasitus TA, Glickman RM. Isolation of high density lipoproteins from rat intestinal epithelial cells. J Clin Invest 1985;75:209-18.
15. Levy E, Mehran M, Seidman E. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 1995;9:626-35.
16. Levy E, Thibault L, Ménard D. Intestinal lipids and lipoproteins in the human fetus: modulation by epidermal growth factor. J Lipid Res 1992;33:1607-17.
17. Loirdighi N, Ménard D, Levy E. Insulin decreases chylomicron production in human fetal intestine. Biochim Biophys Acta 1992;1175:100-6.
18. Reue KL, Quon DH, O'Donnell KA, Dizikes GJ, Fareed GC, Lusis AJ. Cloning and regulation of messenger RNA for mouse apolipoprotein E. J Biol Chem 1984;259:2100-7.
19. Mazzone T, Gump H, Diller P, Getz GS. Macrophage free cholesterol content regulates apolipoprotein E synthesis. J Biol Chem 1987;262:11657-62.
20. Soutar AK, Myant NB, Thompson GR. Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis 1977;28:247-56.
21. Kane JP. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol 1983;45:637-50.
22. Green PHR, Glickman RM. Intestinal lipoprotein metabolism. J Lipid Res 1981;22:1153-73.
23. Breslow JL. Genetic basis of lipoprotein disorders. J Clin Invest 1989;84:373-80.
24. Glickman RM, Rogers M, Glickman JN. Apolipoprotein B synthesis by human liver and intestine in vitro. Proc Natl Acad Sci U S A 1986;83:5296-300.
25. Chen S-H, Habib G, Yang C-Y, Gu Z-W, Lee BR, Weng S-A, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987;238:363-6.
26. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein B-48 in intestine. Cell 1987;50:831-40.
27. Teng BB, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 1993;264:1816-9.
28. Levy E, Rochette C, Londono I, Roy CC, Milne RW, Marcel Y, et al. Apolipoprotein B-100: immunolocalization and synthesis in human intestinal mucosa. J Lipid Res 1990;31:1937-46.
29. Hoeg JM, Sviridov DD, Tennyson GE, Demosky SJ Jr, Meng MS, Bojanovski D, et al. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res 1990;31:1761-9.
30. Herbert PN, Assmann G, Gotto AM Jr, Fredrickson DS. Familial lipoprotein deficiency: abetalipoproteinemia, hypobetalipoproteinemia and Tangier's disease. In: Stanbury JB, Wyngarden JB, Fredrickson DS, Goldstein JL, Brown MS, editors. The metabolic basis of inherited disease. New York: McGraw-Hill, 1987: 695-707.
31. Granot E, Deckelbaum RJ. Hypocholesterolemia in childhood. J Pediatr 1989;115:171-85.
32. Mars H, Lewis LA, Robertson AL, Butkus A, Williams GH. Familial hypobetalipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement. Am J Med 1969;46:886-99.
33. Scott B, Miller JP, Losowsky MS. Hypobetalipoproteinemia: a variant of the Bassen-Korzweig syndrome. Gut 1979;20:163-8.
34. Kudo A, Tanaka N, Oogaki S, Niimura T, Kanehia T. Hypobetalipoproteinemia with abnormal prebetalipoprotein. J Neurol Sci 1977;31:411-9.
35. Steinberg D, Grundy SM, Mok HYI, Turner JD, Weinstein DB, Brown VW, et al. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypoalphalipoproteinemia and fasting chylomicronemia. J Clin Invest 1979;64:292-301.
36. Young SG, Linton MRF. Genetic abnormalities in apolipoprotein B. Trends Cardiovasc Med 1991;1:59-65.
37. Levy E, Roy CC, Thibault L, Bonin A, Brochu P, Seidman EG: Variable expression of familial heterozygous hypobetalipoproteinemia: transient malabsorption during infancy. J Lipid Res 1994;35:2170-7.
38. Krul ES, Kinoshita M, Talmud P, Humphries SE, Turner S, Goldberg AC, et al. Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. Arteriosclerosis 1989;9:856-68.
39. Talmud P, King-Underwood L, Krul E, Schonfeld G, Humphries S. The molecular basis of truncated forms of apolipoprotein B in a kindred with compound heterozygous hypobetalipoproteinemia. J Lipid Res 1989;30:1773-9.
40. Young SG, Bertics SJ, Curtiss LK, Witztuns JL. Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia. J Clin Invest 1987;79:1831-41.
41. Young SG, Hubl ST, Chappell DA, Smith RS, Clairbone F, Snyder SM, et al. Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46). N Engl J Med 1989;320: 1604-10.
42. Wagner RD, Krul ES, Tang K, Parhofer G, Garlock K, Talmud P, et al. Apo B-54.8, a truncated apolipoprotein found primarily in VLDL, is associated with a nonsense mutation in the apo B gene and hypobetalipoproteinemia. J Lipid Res 1991;32:1001-11.
43. Young SG. Recent progress in understanding apolipoprotein B. Circulation 1990;82:1574-94.
44. Levy E, Seidman EG. Genetic aspects of disorders in β-lipoproteins. J Pediatr Gastroenterol Nutr 1992; 14:472-3.
45. Farese RV, Linton MF, Young SG. Apolipoprotein B gene mutations affecting cholesterol levels. J Intern Med 1992;231:643-52.
46. Huang LS, Rifps ME, Horman SH, Deckelbaum RJ. Breslow JL. Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem 1989;264:11394-400.
47. Collins DR, Knott TJ, Pease RJ, Powell LM, Wallis SC, Robertson S, et al. Truncated variants of apolipoprotein B cause hypobetalipoproteinemia. Nucleic Acids Res 1987;16:8361-75.
48. Vega GL, Bergmann KV, Grundy SM, Beltz W, Jahn C, East C. Increased catabolism of VLDL-apolipoprotein B and synthesis of bile acids in a case of hypobetalipoproteinemia. Metabolism 1987;36:262-9.
49. Fazio S, Sidoli A, Vivenzio A, Maietta A, Giampaoli S, Menotti A, et al. A form of familial hypobetalipoproteinemia not due to a mutation in the apolipoprotein B gene. J Intern Med 1991;229:41-7.
50. Demmer LA, Levin MS, Elovson J, Reuben MA, Lusis AJ, Gordon JI. Tissue-specific expression and developmental regulation of the rat apolipoprotein B gene. Proc Natl Acad Sci U S A 1986;90:8102-6.
51. Farese RB Jr, Ruland SL, Flynn LM, Stokowski RP, Young SG. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci U S A 1995;92:1774-78.
52. Purcell-Huynh DA, Farese RV, Johnson DF, Flynn LM, Pierotti V, Newland DL, et al. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 1995;95:2246-57.
53. Jacobs DR, Blackburn H, Higgins M. Report of the conference on low blood cholesterol/mortality associations. Circulation 1992;86:1046-60.
54. Muldoon MF, Marluck SB, Mathews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301: 309-14.
55. Salt HB, Wolff OH, Lloyd JK, Fosbrooke AS, Cameron H, Hubble DV. On having no beta-lipoprotein: a syndrome comprising abeta-lipoproteinemia, acanthocytosis, and steatorrhea. Lancet 1960;2:325-29.
56. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:1139-64.
57. Infante R, Pessah M. Untitled chapter. In: Stein O, Eisenberg S, Stein Y, editors. Atherosclerosis IX. Tel Aviv, Israel: R & L Creative Communications, 1992:189-93.
58. Rader DJ, Brewer HB Jr. Abetalipoproteinemia: new insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease. JAMA 1992; 270:865-9.
59. Shepherd J, Caslake M, Farish E, Fleck A. Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma. J Clin Pathol 1978;31:382-7.
60. Illingworth DR, Connor WE, Alaupovic P. High density lipoprotein metabolism in a patient with abetalipoproteinemia. Ann Nutr Metab 1981;25:1-10.
61. Schaefer EJ, Ordovas JM. Metabolism of apolipoprotein A-I, A-II, and A-IV. Methods Enzymol 1986; 129:420-43.
62. Ikewaki K, Rader DJ, Zech LA, Brewer HB Jr. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism. J Lipid Res 1994;35:1809-19.
63. Glickman RM, Green PHR, Lees R. Immunofluorescence studies of apolipoprotein B in normal and abetalipoproteinemia intestinal mucosa. Gastroenterology 1979;76:288-92.
64. Levy E, Marcel R, Milne RW, Grey VL, Roy C. Absence of intestinal synthesis of apolipoprotein B-48 in two cases of abetalipoproteinemia. Gastroenterology 1987;93:1119-26.
65. Dullaart RPF, Speelberg B, Schuurman GH, Milne RW, Havekes LM, Marcel Y, et al. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine: expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest 1986;78:1397-404.
66. Lackner KJ, Monge JC, Gregg RE, Hoeg JM, Triche TJ, Law SW, et al. Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J Clin Invest 1986;78:1707-12.
67. Talmud PJ, Lloyd JK, Muller DPR, Collins DR, Scott J, Humphries S. Genetic evidence that the apolipoprotein B gene is not involved in abetalipoproteinemic plasma. J Clin Invest 1988;82:1803-6.
68. Bouma ME, Beucler I, Pessah M, Heinzmann C, Lussis AJ, Naim HY, et al. Description of two different patients with abetalipoproteinemia: synthesis of a normal-sized apolipoprotein B-48 in intestinal organ cultue. J Lipid Res 1990;31:1-15.
69. Wetterau JR, Combs KA, Spinner SN, Joiner BJ. Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J Biol Chem 1990;265:9800-7.
70. Wetterau JR, Combs KA, McLean LR, Spinner SN, Aggerbeck LP. Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry 1991;30:9728-35.
71. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992;258:999-1001.
72. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993;365:65-9.
73. Roy CC, Levy E, Green PHR, Sniderman A, Letarte J, Buts JP, et al. Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease. Gastroenterology 1987;92:390-9.
74. Levy E, Marcel Y, Deckelbaum RJ, Milne R, Lepage G, Seidman E, et al. Intestinal apo B synthesis, lipids, and lipoproteins in chylomicron retention disease. J Lipid Res 1987;28:1263-74.
75. Pessah M, Benlian P, Beucler I, Loux N, Schmitz J, Junien C, et al. Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families. J Clin Invest 1991;87:367-70.